Press Releases

LONDON, May 22, 2024 /PRNewswire/ -- Prepare for an exciting keynote at the London Blockchain Conference; top business and tech marketing expert Steven Bartlett opens today's conference.

Today will also feature Boston Consulting Group Managing Director and Partner Tibor Merey, who will take the stage in the afternoon to discuss best practices for enterprise blockchain adoption.

Finally, tune in for an insightful discussion following one of the biggest cyclical... (continue reading...)

TOKYO, May 22, 2024 - (JCN Newswire) - - Mitsubishi Heavy Industries, Ltd. (MHI) and NGK INSULATORS, LTD. (NGK) will jointly develop two membrane dehydration systems to realize of low cost and to optimize efficiency of manufacturing processes for Bioethanol and e-Methanol to meet expected demand growth for clean fuels and raw materials.

In this project, MHI and NGK will begin developing two types of membrane dehydration systems, one for Bioethanol and e-Methanol,... (continue reading...)

TOKYO, May 22, 2024 - (ACN Newswire) - - ArcelorMittal and partners Mitsubishi Heavy Industries, Ltd. (MHI), BHP, along with Mitsubishi Development Pty Ltd (Mitsubishi Development) have successfully started operating a pilot carbon capture unit on the blast furnace off-gas at ArcelorMittal Gent in Belgium.

The pilot carbon capture unit will operate for one to two years at Gent, to test the feasibility of progress to full-scale deployment of the technology, which would... (continue reading...)

TOKYO, May 22, 2024 - (JCN Newswire) - - Eisai Co., Ltd. and nippon medac Co., Ltd., a subsidiary of medac group announced today that they have launched the anti-rheumatic agent "Metoject Subcutaneous Injection 7.5mg Pen 0.15mL, 10mg Pen 0.20mL, 12.5mg Pen 0.25mL and 15mg Pen 0.30mL" (methotrexate, "MTX"), in Japan. The product received manufacturing and marketing approval in Japan on February 15, 2024, and was published in Japan's National Health Insurance Drug Price... (continue reading...)

BEIJING, May 22, 2024 /PRNewswire/ -- Docking is crucial in the early stages of drug discovery as it enables the efficient screening of vast libraries of compounds, saving time and resources. In recent years, AI-based methods have emerged as promising alternatives for molecular docking, offering the potential for high accuracy without incurring prohibitive computational costs. Advancing AI for Science, DP Technology has recently open-sourced its powerful... (continue reading...)